A Chymotrypsin Substrate I, Colorimetric CEP of the European Pharmacopoeia monograph is often referred to as a Chymotrypsin Substrate I, Colorimetric Certificate of Suitability (COS). The purpose of a Chymotrypsin Substrate I, Colorimetric CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Chymotrypsin Substrate I, Colorimetric EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Chymotrypsin Substrate I, Colorimetric to their clients by showing that a Chymotrypsin Substrate I, Colorimetric CEP has been issued for it. The manufacturer submits a Chymotrypsin Substrate I, Colorimetric CEP (COS) as part of the market authorization procedure, and it takes on the role of a Chymotrypsin Substrate I, Colorimetric CEP holder for the record. Additionally, the data presented in the Chymotrypsin Substrate I, Colorimetric CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Chymotrypsin Substrate I, Colorimetric DMF.
A Chymotrypsin Substrate I, Colorimetric CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Chymotrypsin Substrate I, Colorimetric CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Chymotrypsin Substrate I, Colorimetric suppliers with CEP (COS) on PharmaCompass.